Ultrasound-enhanced Delivery of Chemotherapy to Patients With Liver Metastasis From Breast- and Colorectal Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

November 12, 2018

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Colorectal NeoplasmsBreast Neoplasms
Interventions
DRUG

SonoVue

"consists of microbubbles containing sulfur hexafluoride stabilized by phospholipids.~Bolus doses à 1,0ml administered every 3.5 minutes , repeated 9 times. Total duration of treatment: 31,5 minutes. This treatment will be repeated maximally 4 times at 2 or 3 week intervals, depending on the patient's diagonse and treatment protocol."

PROCEDURE

Focused Ultrasound

ultrasound pulses will be generated by a clinically approved ultrasound skanner and probe.

Trial Locations (1)

Unknown

St.Olavs Hospital, Trondheim

All Listed Sponsors
lead

St. Olavs Hospital

OTHER

NCT03477019 - Ultrasound-enhanced Delivery of Chemotherapy to Patients With Liver Metastasis From Breast- and Colorectal Cancer | Biotech Hunter | Biotech Hunter